Hwg Holdings LP Zymeworks Inc. Transaction History

Hwg Holdings LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$33.67 - $40.0 $141,077 - $167,600	-4,190 Closed	0 $0
Q4 2019 Jan 09, 2020	BUY	$24.84 - $45.46 $61,056 - $111,740	2,458 Added 141.92%	4,190 $190,000
Q3 2019 Nov 20, 2019	BUY	$22.78 - $29.08 $25,422 - $32,453	1,116 Added 181.17%	1,732 $43,000
Q1 2019 Apr 29, 2019	BUY	$14.02 - $16.74 $8,636 - $10,311	616 New	616 $10,000

296K

Ticker ZYME
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,694,400
Market Cap $917M
Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...

Get notified when there are updates to the investment portfolio of Hwg Holdings LP, based on Form 13F filings with the SEC.

Stay updated on Hwg Holdings LP with notifications on news.